Literature DB >> 1834467

Scintigraphic evaluation of myocardial uptake of thallium 201 and technetium 99m pyrophosphate utilizing a rat model of chronic doxorubicin cardiotoxicity.

M Miyagawa1, S Tanada, K Hamamoto.   

Abstract

To evaluate the usefulness of myocardial scintigraphy as a monitoring tool for chronic doxorubicin (DXR) cardiotoxicity, a rat model was used to investigate the relationship between the myocardial uptake of thallium 201 (Tl) or rechnetium 99m pyrophosphate (99mTc-PPi) and histological changes of the heart. Although there was no significant difference in myocardial Tl uptake between control and DXR-treated rats at an early phase after Tl injection, late-phase Tl uptake was significantly higher in the DXR-treated rats than in the control rats, indicating a slow wash-out of Tl from the myocardium. The wash-out rate calculated from scintigraphic examination of DXR-treated rats was significantly decreased with increasing degree of cardiomyopathy. Since the Tl wash-out rate was sharply decreased even in animals with minimal histological changes, it may be a possible monitoring tool for the early detection of chronic DXR cardiotoxicity. On the other hand, myocardial 99mTc-PPi images could be obtained only in rats with severe myocardial changes and hence would not useful for early detection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834467     DOI: 10.1007/bf02285461

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  25 in total

1.  Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.

Authors:  F P Mettler; D M Young; J M Ward
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

2.  Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity.

Authors:  Y Iwamoto; I L Hansen; T H Porter; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1974-06-04       Impact factor: 3.575

3.  Generation of free radicals of quinone group-containing anti-cancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation.

Authors:  K Handa; S Sato
Journal:  Gan       Date:  1975-02

4.  Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.

Authors:  S Al-Ismail; J A Whittaker
Journal:  Br Med J       Date:  1979-05-26

5.  Risk factors for doxorubicin-induced congestive heart failure.

Authors:  D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

6.  Anthracycline cardiomyopathy monitored by morphologic changes.

Authors:  M E Billingham; J W Mason; M R Bristow; J R Daniels
Journal:  Cancer Treat Rep       Date:  1978-06

7.  Differential effect of adriamycin on DNA replicative and repair synthesis in cultured neonatal rat cardiac cells.

Authors:  H Fialkoff; M F Goodman; M W Seraydarian
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

8.  Electrocardiographic changes after adriamycin chemotherapy.

Authors:  M K Ali; A Soto; D Maroongroge; S Bekheit-Saad; A U Buzdar; G R Blumenschein; G N Hortobagyi; C K Tashima; C L Wiseman; C C Shullenberger
Journal:  Cancer       Date:  1979-02       Impact factor: 6.860

9.  Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse.

Authors:  C Bertazzoli; O Bellini; U Magrini; M G Tosana
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

10.  Chronic cardiotoxicity of doxorubicin (adriamycin) in the rat: morphologic and biochemical investigations.

Authors:  H M Olson; C C Capen
Journal:  Toxicol Appl Pharmacol       Date:  1978-06       Impact factor: 4.219

View more
  2 in total

1.  Assessing anthracycline cardiotoxicity in the 1990s.

Authors:  I Carrió; M Estorch; A López-Pousa
Journal:  Eur J Nucl Med       Date:  1996-04

2.  Noninvasive identification of anthracycline cardiotoxicity: comparison of 123I-MIBG and 123I-BMIPP imaging.

Authors:  Y Takeishi; H Sukekawa; T Sakurai; H Saito; S Nishimura; T Shibu; Y Sasaki; H Tomoike
Journal:  Ann Nucl Med       Date:  1994-08       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.